Single use Bioreactors Market

GMI Research analysis indicates that the Single use Bioreactors Market estimated at USD 2.9 billion in 2021 and is slated to register a double digit CAGR 18.7% over the period, 2022-2029 and is projected to reach USD 11.4 billion in 2029

To have an edge over the competition by knowing the market dynamics and current trends of “Single-Use Bioreactors Market”, request for Sample Report here

Market Dynamic

Key Drivers and Emerging Trends

The rise of single-use bioprocessing technologies has significantly contributed to the bioreactors’ rising demand. This is due to the bioreactor’s several advantages, such as it takes only two hours for the process compared to the other vessel container bioreactor. The production of pharmaceutical products, while using single-use bioreactor has helped the pharmaceutical industry to grow by reducing the batch culture time, thus leading to the changed landscape of the market. In addition, this bioreactor has penetrated clinical manufacturing and dominated most of the research and development action plans. Key players present in the market are involved in offering a list of single use bioreactors that have expanded the reach of the product and surged the market’s growth globally. For instance, Applikon Biotechnology, Pall Corporation, Sartorius AG have wide product portfolio & AppliFlex, HyClone S.U.B., ATMI iCELLis Nano etc. offered by Applikon Biotechnology. One of the leading benefits of the acceptance of single‑use bioreactors is its flexibility. The escalating trend in the direction of multi‑drug facilities calls the production of several drugs, utilizing the same facility, in bare minimum time and with lowest possible costs, leading to the overall growth of the market.

Restraint in the Single-Use Bioreactors Market

However, stringent policies in bioreactor manufacturing are likely to hamper the growth of the market over the forecast period.

Do you want to know more about the Research process and detailed Methodology, Request Research Methodology of this report

Cell Type – Segment Analysis

Based on the cell type, the mammalian cell is expected to grow at a higher CAGR in the market over the forecast period. This is due to the expressional ability of mammalian cells in larger quantities compared to other cell types and makes the complex procedure easy and less culture consuming, which helps overcome the limitations.

In case, any of your pain points areas are not covered in the current scope of this report, Request for Free Customization here

Regional – Segment Analysis:

Based on the region, North America is expected to dominate the market over the forecast period. This can be attributed to the presence of well-developed biopharmaceutical manufacturing coupled with the presence of major players operating in the single-use bioreactors market in North America. For instance, ABEC INC, Pall Corporation, have strong presence in the region. In addition, Abzena, a pharmaceutical company, began the installation of a new 500L BIOSTAT STR, single-use bioreactor, as part of a series of significant investments in its San Diego process development and manufacturing operations, which shows the huge potential in the coming years.

Top Market Players

Various notable players operating in the market, include, Applikon Biotechnology, Sartorius AG, ABEC INC., Celltainer, Distek Inc., GE Healthcare, Merck KGaA, OmniBRx Biotechnologies, Pall Corporation, Sartorius AG, among others. 

Key Developments:

• • In 2019, Applikon Biotechnology officially announced the launch of fully customizable single-use bioreactor using 3D printing technology which has helped the company in expanding the product portfolio.

Segments covered in the Report:

The global single-use bioreactors market has been segmented based on type, type of molecule, cell type and regions. Based on type, the market is segmented into stirred tank single-use bioreactors, bubble column single-use bioreactors, and wave induced single-use bioreactors. Based on type of molecule, the market is segmented into monoclonal antibodies (MAbs), vaccine, stem cells, gene–modified cells, and other molecules. Based on cell type the market is segmented into mammalian cells, bacteria cells, yeast cells and others. Based on application the market is segmented into research and development, process development and bioproduction. 

For detailed scope of the “Single-Use Bioreactors Market” report request a Sample Copy of the report

Key questions answered in this research report:

• • At what pace is global single-use bioreactors market growing? What will be the growth trend in the future?
  • What are the key drivers and restraints in single-use bioreactors market? What will be the impact of drivers and restraints in the future?
  • What are the regional revenues and forecast breakdowns? Which are the major regional revenue pockets for growth in the global single-use bioreactors market?
  • Which product generated maximum revenues in 2021 and identify the most promising product during the forecast period?
  • What are the various type areas of global single-use bioreactors market and how they are poised to grow?
  • What companies are the major participants in this market and their business strategies, how does the competitive landscape look like?

Report Coverage	Details
Market Revenues (2021)	USD 2.9 Billion
Market Base Year	2021
Market Forecast Period	2022-2029
Base Year & Forecast Units	Revenues (USD Billion)
Market Segment	By Type, By Type of Molecule, By Cell Type, By Application, By End-User and By Region
Regional Coverage	Asia Pacific, Europe, North America, and RoW
Companies Profiled	Applikon Biotechnology, Sartorius AG, ABEC INC., Celltainer, Distek Inc., GE Healthcare, Merck KGaA, OmniBRx Biotechnologies, Pall Corporation, Sartorius AG, among others; a total of 10 companies covered.
25% Free Customization Available	We will customize this report up to 25% as a free customization to address our client’s specific requirements

Market Segmentation

Global Single-Use Bioreactors Market by Type

• • Stirred Tank Single-use Bioreactors
  • Bubble Column Single-use Bioreactors
  • Wave Induced Single-use Bioreactors

Global Single-Use Bioreactors Market by Type of Molecule

• • Monoclonal Antibodies (MAbs)
  • Vaccine
  • Stem Cells
  • Gene–Modified Cells
  • Other Molecules

Global Single-Use Bioreactors Market by Cell Type

• • Mammalian Cells
  • Bacteria Cells
  • Yeast Cells
  • Others

Global Single-Use Bioreactors Market by Application

• • Research and Development
  • Process Development
  • Bioproduction

Global Single-Use Bioreactors Market by End-User

• • Pharmaceutical and Biopharmaceutical Companies
  • Academic and Research Institutes
  • Contract Research Organizations (CROs)
  • Contract Manufacturing Organizations (CMOs)
  • Others

Global Single-Use Bioreactors Market by Region

• • North America Single-Use Bioreactors Market (Option 1: As a part of the free 25% customization)
    • By Type
    • By Type of Molecule
    • By Cell Type
    • By Application
    • By End-User
    • US Market All-Up
    • Canada Market All-Up
  • Europe Single-Use Bioreactors Market (Option 2: As a part of the free 25% customization)
    • By Type
    • By Type of Molecule
    • By Cell Type
    • By Application
    • By End-User
    • UK Market All-Up
    • Germany Market All-Up
    • France Market All-Up
    • Spain Market All-Up
    • Rest of Europe Market All-Up
  • Asia-Pacific Single-Use Bioreactors Market (Option 3: As a part of the free 25% customization)
    • By Type
    • By Type of Molecule
    • By Cell Type
    • By Application
    • By End-User
    • China Market All-Up
    • India Market All-Up
    • Japan Market All-Up
    • Rest of APAC Market All-Up
  • RoW Single-Use Bioreactors Market (Option 4: As a part of the free 25% customization)
    • By Type
    • By Type of Molecule
    • By Cell Type
    • By Application
    • By End-User
    • Brazil Market All-Up
    • South Africa Market All-Up
    • Saudi Arabia Market All-Up
    • UAE Market All-Up
    • Rest of world (remaining countries of the LAMEA region) Market All-Up

Major Players Operating in the Single-Use Bioreactors (Option 5: As a part of the Free 25% Customization – Profiles of 5 Additional Companies of your Choice)

• • Applikon Biotechnology
  • Sartorius AG
  • ABEC INC.
  • Celltainer
  • Distek Inc.
  • GE Healthcare
  • Merck KGaA
  • OmniBRx Biotechnologies
  • Pall Corporation
  • Sartorius AG